Senexin A

CAT: 0804-HY-15681-01Size: 2 mgDry Ice: NoHazardous: No
CAT#:0804-HY-15681-01Size:2 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Senexin A is an inhibitor of CDK8/19 (IC50: 280 nM, CDK8) and an inhibitor downstream of p21 transcription. It only inhibits p21-induced transcription but does not inhibit other biological effects of p21. Senexin A inhibits CMV-GFP induction as well as the p21 stimulatory activity of the consensus NF-κB-dependent promoters[1][2].
CAS Number
[1366002-50-7]
UNSPSC
12352005
Hazard Statement
H302, H312, H315, H319, H332
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Senexin_A.html
Purity
99.79
Solubility
DMSO : ≥ 100 mg/mL
Smiles
N#CC1=CC=C2C(C(NCCC3=CC=CC=C3)=NC=N2)=C1
Molecular Formula
C17H14N4
Molecular Weight
274.32
Precautions
H302, H312, H315, H319, H332
References & Citations
[1]Porter DC, et al. Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities. Proc Natl Acad Sci U S A. 2012 Aug 21;109 (34) :13799-804.|[2]Ho TY, et al. The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo. Biomed Pharmacother. 2023 Jun;162:114667.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK19; CDK8

Alternative Products

CatalogName
4875/10Senexin A
MBS3601512-01Senexin-A
MBS5759228Senexin B
A21166-1Senexin A 1mg
A21166-200Senexin A 200mg
MF-0120124-01Senexin A hydrochloride
A21166-2Senexin A 2mg
A21166-10Senexin A 10mg
A21166-25Senexin A 25mg
A21166-50Senexin A 50mg

Popular Products